Bio-Techne
TECH
#1477
Rank
NZ$20.22 B
Marketcap
$127.32
Share price
-0.50%
Change (1 day)
30.37%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Revenue for Bio-Techne (TECH)

Revenue in 2024 (TTM): NZ$1.90 Billion

According to Bio-Techne's latest financial reports the company's current revenue (TTM ) is NZ$1.94 Billion. In 2023 the company made a revenue of NZ$1.81 Billion an increase over the revenue in the year 2022 that were of NZ$1.76 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Techne from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$1.90 B5.16%
2023 NZ$1.81 B2.65%
2022 NZ$1.76 B17.01%
2021 NZ$1.50 B36.13%
2020 NZ$1.10 B0.14%
2019 NZ$1.10 B8.8%
2018 NZ$1.01 B20.42%
2017 NZ$0.84 B10.69%
2016 NZ$0.76 B12.19%
2015 NZ$0.67 B30.34%
2014 NZ$0.52 B29.77%
2013 NZ$0.40 B5.79%
2012 NZ$0.37 B-3.32%
2011 NZ$0.39 B11.15%
2010 NZ$0.35 B-3.07%
2009 NZ$0.36 B-21.2%
2008 NZ$0.46 B48.44%
2007 NZ$0.31 B3.71%
2006 NZ$0.30 B7.43%
2005 NZ$0.27 B18.71%
2004 NZ$0.23 B-0.14%
2003 NZ$0.23 B-10.35%
2002 NZ$0.26 B-10.35%
2001 NZ$0.29 B19.92%
2000 NZ$0.24 B30.8%
1999 NZ$0.18 B24.71%
1998 NZ$0.15 B37.17%
1997 NZ$0.10 B33.99%
1996 NZ$81.67 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$70.97 B 3,553.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.32 B 122.61%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$33.23 B 1,610.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$33.57 B 1,628.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.25 B 67.39%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$91.19 B 4,594.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$53.47 M-97.25%๐Ÿ‡บ๐Ÿ‡ธ USA